AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTechZacks Investment Research • 02/20/26
Unlocking Q4 Potential of Tempus (TEM): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 02/19/26
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week's Earnings24/7 Wall Street • 02/18/26
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?Zacks Investment Research • 02/18/26
Tempus AI & Median Partner to Add AI Lung Cancer Screening to PixelZacks Investment Research • 02/17/26
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?Zacks Investment Research • 02/13/26
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel PlatformBusiness Wire • 02/12/26
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United StatesBusiness Wire • 02/12/26
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24Business Wire • 02/10/26
Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New GenesBusiness Wire • 02/04/26
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and YieldBusiness Wire • 02/02/26
TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom?Zacks Investment Research • 01/29/26
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional BiomarkersBusiness Wire • 01/27/26
Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto TransportNewsfile Corp • 01/26/26